FIELD: chemistry.
SUBSTANCE: present invention relates to compounds selected from a group, structural formulae and values of radicals as given in paragraph 1 and paragraph 9 of the claim, as well as a method of treating a cell proliferation-associated disease, involving administration of said compounds to a subject.
EFFECT: novel compounds which exhibit considerable activity as Jak2/STAT3 pathway and subsequent target inhibitors and inhibit growth and survival of tumour cell lines are obtained and described.
52 cl, 3 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AMYLOID-BINDING AGENTS | 2010 |
|
RU2517174C2 |
| NEW SALICYLIC ACID DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALT, COMPOSITIONS AND METHOD FOR APPLICATION | 2013 |
|
RU2641903C2 |
| ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS FOR USING IT | 2006 |
|
RU2448703C2 |
| SPIRO OXINDOLE MDM2 ANTAGONISTS | 2010 |
|
RU2553269C2 |
| MDM2 PROTEIN DESTRUCTORS | 2017 |
|
RU2743432C2 |
| TAXANE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | 1994 |
|
RU2137764C1 |
| N- (PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2744358C2 |
| N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2722560C1 |
| LOW-MOLECULAR INHIBITORS OF N-TERMINUS ACTIVATION OF ANDROGEN RECEPTOR | 2009 |
|
RU2519948C2 |
| BENZOXAZINE-OXAZOLIDINONE COMPOUND DISPLACED BY A NITROGEN-CONTAINING HETEROCYCLE, METHOD OF SYNTHESIS AND APPLICATION THEREOF | 2018 |
|
RU2744784C1 |
